744200-35-9Relevant academic research and scientific papers
VASOPRESSIN V1A ANTAGONISTS
-
Page/Page column 30, (2008/06/13)
The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V 1a receptor antagonists. Pharmaceutical compositions of the compounds are useful as treatment of dysmenorrhoea.
Piperazines as oxytocin agonists
-
Page/Page column 11-12, (2010/02/11)
Disclosed are novel compounds according to general formula I, which have shown OT agonist activity.
benzamide derivatives as oxytocin agonists and vasopressin antagonists
-
Page 25, (2010/02/08)
Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group that are specific OT receptor agonists and/or Via receptor antagonists. Pharmaceutical compositions comprising such compounds are useful in the treatment of, inter alia, primary dysmenorrhoea.
